Tech Company Financing Transactions
InfraReDx Funding Round
On 10/12/2010, InfraReDx raised $21 million in Series D funding from Sanderling Ventures and private investors.
Transaction Overview
Company Name
Announced On
10/12/2010
Transaction Type
Venture Equity
Amount
$21,000,000
Round
Series D
Investors
Sanderling Ventures (Robert McNeil)
Proceeds Purpose
Funds from the financing are being used to support the full commercial launch of the LipiScan IVUS Coronary Imaging System, the world's first and only intravascular imaging system that combines and co-registers grayscale intravascular ultrasound (IVUS) with InfraReDx's proprietary near infrared (NIR) spectroscopy lipid core plaque (LCP) detection technology.
Company Information
Company Status
Acquired or Merged
Industry
Medical Devices & Instruments
Mailing Address
34 Third Avenue
Burlington, MA 01803
USA
Burlington, MA 01803
USA
Phone
Website
Email Address
Overview
The company has now developed a fiber-optic, catheter-based, near infrared (NIR) spectroscopy system designed to characterize the composition of coronary plaques in patients undergoing catheterization. This NIR system is currently being evaluated in a clinical study.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Donald Southard
Chief Financial Officer
Michael Guarasci
Chief Medical Officer
James Muller
VP - Marketing
Grant Frazier
VP - Operations
Steve Chartier
VP - R & D
Stephen Sum
VP - Sales
Jason Bottiglieri
Browse more venture capital transactions:
Prev: 10/12/2010: HealthUnity venture capital transaction
Next: 10/13/2010: FamilyFinds venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs